A Braf kinase-inactive mutant induces lung adenocarcinoma-Reference-Cited by-同舟云学术

A Braf kinase-inactive mutant induces lung adenocarcinoma

Published:2017-08 Issue:7666 Volume:548 Page:239-243
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Nieto Patricia,Ambrogio Chiara,Esteban-Burgos Laura,Gómez-López Gonzalo,Blasco María Teresa,Yao Zhan,Marais Richard,Rosen Neal,Chiarle Roberto,Pisano David G.,Barbacid Mariano,Santamaría David

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature23297.pdf

Reference31 articles.

1. Chang, M. T. et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat. Biotechnol. 34, 155–163 (2016)

2. Heidorn, S. J. et al. Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell 140, 209–221 (2010)

3. Poulikakos, P. I., Zhang, C., Bollag, G., Shokat, K. M. & Rosen, N. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 464, 427–430 (2010)

4. Sebolt-Leopold, J. S. & Herrera, R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4, 937–947 (2004)

5. Rauen, K. A. The RASopathies. Annu. Rev. Genomics Hum. Genet. 14, 355–369 (2013)

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interference with ANXA8 inhibits the malignant progression of ovarian cancer by suppressing the activation of the Wnt/β-catenin signaling pathway via UCHL5;Aging;2024-07-26

2. Enzyme Is the Name—Adapter Is the Game;Cells;2024-07-25

3. Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation;eLife;2023-12-27

4. Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation;eLife;2023-12-27

5. Prognostic and predictive biomarkers in non-small cell lung carcinoma;Pathology;2023-12